The Traderszone Network

25 April, 2016 by The TZ Newswire Staff Comments Off on Expect silver to stay strong: Trader

Expect silver to stay strong: Trader

A bullish bet on silver futures

25 April, 2016 by The TZ Newswire Staff Comments Off on While America Debates The $20 Bill, China Moves Closer To Gold

While America Debates The $20 Bill, China Moves Closer To Gold

Submitted by Tho Bishop via The Mises Institute,

read more

25 April, 2016 by The TZ Newswire Staff Comments Off on We Don’t Need Cellular Apple Watches

We Don’t Need Cellular Apple Watches

A cellular Apple Watch might work in a shared data plan, but not everyone has those.

25 April, 2016 by The TZ Newswire Staff Comments Off on This trend is ‘profoundly bullish’ for stocks: Bespoke

This trend is ‘profoundly bullish’ for stocks: Bespoke

A year that had been looking pretty bleak for the stock market suddenly appears to be turning a corner.

25 April, 2016 by The TZ Newswire Staff Comments Off on For The First Time US Deploys Two F-22 Raptors Close To Russia To "Deter Aggression"

For The First Time US Deploys Two F-22 Raptors Close To Russia To "Deter Aggression"

Tensions are rapidly escalating between the US and Russia following last week two fly-bys when first a Russian Su-24 “buzzed” the US missile destroyer USS Donald Cook in the Baltic Sea, and just days later flew within 50 feet of a US recon plane also flying over the Baltic Sea, which some interpreted as a Russian warning to Poland.

read more

25 April, 2016 by The TZ Newswire Staff Comments Off on Tesco CFO says deflation endemic in UK grocery market

Tesco CFO says deflation endemic in UK grocery market

That’s a spooky headline if you’re the BOE
You don’t often hear chatter about grocery prices falling.
Although the CFO may be confusing his company shares with groceries.

25 April, 2016 by The TZ Newswire Staff Comments Off on Valeant’s new CEO a good choice for a dim future

Valeant’s new CEO a good choice for a dim future

Valeant’s new CEO needs to keep staff, sell assets and pay down the company’s $30 billion of debt, all while coping with drug pricing pressures says Thomson Reuters Breakingviews.